In silico Study of the interaction of fucoidan with thrombolytic agents
Tissue plasminogen activator (tPA) is one of the most widely used drugs in thrombolytic therapy. However, due to the inactivation of tPA in the bloodstream and increased risk of bleeding with increasing tPA dosages, the development of targeted delivery systems of tPA is required. For these purposes,...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Статья |
| Мова: | English |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2022
|
| Предмети: | |
| Онлайн доступ: | https://dspace.ncfu.ru/handle/20.500.12258/21888 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|